Literature DB >> 803529

Antibody-mediated cytotoxicity after measles virus infection.

R Kibler, V T Meulen.   

Abstract

Antibody cytotoxicity in the presence of complement to measles virus-infected cells was determined in sera of individuals at various stages of measles virus infection. A measles virus carrier cell line, which possessed viral antigens on the cell membrane, was employed as target cells. The cytotoxic effect was measured by 51-Cr release from the measles virus-infected cells. A microtiter method was used to determine the titer of antibody cytotoxicity. Cytotoxic antibodies could be detected in serum specimens from individuals after natural measles virus infection and vaccination. Sera from subacute sclerosing panencephalitis (SSPE) patients had only slightly higher titers than were found in sera obtained from individuals 1 week to 3 months after measles virus infection. Sera from children inoculated with measles virus vaccine lost their ability to react in hemagglutination inhibition, neutralization (NT) and cytotoxicity (CT) tests after absorption with the hemagglutinin from measles virus. SSPE sera treated in a similar manner retained their activity in NT and CT tests. Cytotoxic antibody was, therefore, shown to be directed against the hemagglutinin and some other antigen of measles virus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803529

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Transfer factor therapy in patients with subacute sclerosing panencephalitis.

Authors:  Y M Käckell; P J Grob; W H Kreth; R Kibler; V Meulen
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849

2.  Measles virus nucleocapsid protein protects rats from encephalitis.

Authors:  B Bankamp; U G Brinckmann; A Reich; S Niewiesk; V ter Meulen; U G Liebert
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  Natural and immune cytolysis of canine distemper virus-infected target cells.

Authors:  W R Shek; R D Schultz; M J Appel
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

4.  Complement dependen cytotoxic antibody activity against measles virus in multiple sclerosis.

Authors:  V Kratzsch; W R Kiessling
Journal:  J Neurol       Date:  1977-08-18       Impact factor: 4.849

5.  Cytotoxic antibody to cells infected with measles virus in serum and cerebrospinal fluid of multiple sclerosis and control patients.

Authors:  N E Cremer; K P Johnson; G Fein; W H Likosky
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

Review 6.  Antibody-mediated destruction of virus-infected cells.

Authors:  J G Sissons; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.